Volume 17, Issue 5 pp. 735-738
Short Paper
Full Access

The effect of recombinant interferon-γ on human monocyte-derived macrophages

Thomas W. Jungi

Corresponding Author

Thomas W. Jungi

Institute for Clinical and Experimental Cancer Research, University of Berne, Berne

Institute for Clinical and Experimental Cancer Research, University of Berne, Tiefenau Hospital, CH-3004 Berne, SwitzerlandSearch for more papers by this author
Peter G. Lerch

Peter G. Lerch

Central Laboratory, Swiss Red Cross Blood Transfusion Service, Berne

Search for more papers by this author
Marija Brcic

Marija Brcic

Institute for Clinical and Experimental Cancer Research, University of Berne, Berne

Search for more papers by this author
First published: 1987
Citations: 13

Abstract

The effect of recombinant interferon-gamma (rIFN-γ) on human macrophage functions was studied, using monocytes which had matured to macrophages within hydrophobic containers. Following exposure to rIFN-γ, the number of surface-expressed specific IgG-binding sites was increased. This increase was restricted to high-affinity Fc receptors (FcR), however; low-affinity FcR were not increased in number. Exposure to rIFN-γ led to an enhanced chemiluminescence (CL) signal in the presence of luminol and a variety of respiratory burst stimuli, such as zymosan, phorbol 12-myristate 13-acetate or IgG-sensitized sheep erythrocytes (EA). In contrast, phagocytosis of EA was markedly depressed in rIFN-γ-treated cells. Both increase in CL response and decrease in phagocytic activity were manifest after 1 day of treatment and were more pronounced after 2 days. While 5 U/ml of rIFN-γ was an insufficient dose, 50 to 5000 U/ml yielded significant dose-dependent changes in both functional assays. Thus, using rIFN-γ as a biological response-modifier, FcR expression and FcR-mediated CL can be dissociated from FcR-mediated phagocytosis.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.